The Elective Primary Hip Arthroplasty episode-based cost measure evaluates a clinician’s risk-adjusted cost to Medicare for patients who receive an elective primary hip arthroplasty during the performance period. The measure score is a clinician’s risk-adjusted cost for the episode group averaged across all episodes attributed to the clinician. This procedural measure includes costs of services that are clinically related to the attributed clinician’s role in managing care during each episode from the 30 days prior to the clinical event that opens or “triggers” the episode, through 90 days after the trigger. Patient populations eligible for the Elective Primary Hip Arthroplasty measure include Medicare beneficiaries enrolled in Medicare Parts A and B.
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.9 Care Setting1.20 Testing Data Sources
-
Most Recent Endorsement ActivityEndorsed Cost and Efficiency Spring 2022Initial EndorsementLast Updated
-
StewardCenters for Medicare & Medicaid ServicesSteward Organization POC Email
-
-
-
Risk Adjustment
-
-
-
6.1.2 Current or Planned Use(s)6.1.3 Current Use(s)
-